Table 2 Annual trends associated with successful I-ASV
From: Predictive factors for successful INTELLiVENT-ASV® use: a retrospective observational study
Year | 2016 | 2017 | 2018 |
|---|---|---|---|
Number of included patients | n = 29 | n = 68 | n = 92 |
I-ASV success, (n) | 69.0% (20) | 72.1% (49) | 71.7% (66) |
APACHE II | 19 (17–27) | 17 (15–25) | 23 (18–27) |
SOFA (day1) | 8 (5–10) | 7 (6–10) | 10 (7–13) |
Use of vasopressor (day1) | 50.0% | 46.9% | 57.6% |
P/F ratio | 281 (227–365) | 290 (234–391) | 256 (178–337) |
Presence of sepsis | 63.6% | 67.7% | 66.7% |
CKD on HD | 50.0% | 66.7% | 75.0% |
Trauma | 0.0% | 66.7% | 100% |
Reasons for admission | |||
Elective surgery | 85.7% | 94.1% | 100.0% |
Emergent surgery | 69.2% | 75.0% | 90.6% |
Medical reasons | 55.6% | 58.1% | 54.0% |
P/F ratio classification | |||
≥ 300 | 82.4% | 89.5% | 92.3% |
≤ 200 to < 300 | 50.0% | 72.7% | 75.0% |
≤ 100 to < 200 | 60.0% | 37.5% | 52.6% |
< 100 | 33.3% | 33.3% | 35.7% |